Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Subcommittee narrowly advances bill directing Board of Pharmacy to prepare for FDA-approved psilocybin
Summary
SB 11 35 directs the Virginia Board of Pharmacy to promulgate regulations to allow use of FDA‑approved crystalline psilocybin following federal rescheduling; the measure passed the subcommittee 4–3 amid questions about timing and board authority.
Senator Boyseco presented Senate Bill 11 35, which would direct the Virginia Board of Pharmacy to promulgate regulations allowing prescribing, dispensing, possession, and use of FDA‑approved crystalline polymorph psilocybin if and when the U.S. Food and Drug Administration approves the drug and the U.S. Drug Enforcement Administration reschedules it.
Supporters said clinical studies show promise for treatment-resistant depression and PTSD and emphasized the potential for meaningful patient…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
